Entero Therapeutics, Inc. (ENTO) Insider Trading -- Recent Executive & Director Transactions

1 insiders reported 1 Form 4 transactions for Entero Therapeutics, Inc. (ENTO) over the past 18 months (most recent 2025-01-08). Recent activity: Romano Sarah (Chief Financial Officer) Sell 727 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2025-01-08Romano SarahChief Financial OfficerSell727$465

Source: SEC Form 4 filings · as of 2025-01-08